TRNT1 基因突变所致 tRNA 加工异常引起对 TNF 抑制剂有反应的自炎症综合征
研究纳入 9 例 TRNT1 双等位基因突变、先天性铁粒幼细胞性贫血伴免疫缺陷、发热和发育迟缓(SIFD)患者,发现 8 个突变(其中 3 个此前未与 SIFD 关联),炎症细胞因子升高,4/4 例接受 TNF 抑制剂治疗后炎症被抑制、输血需求减少、生长改善。
要点
- TRNT1 双等位基因突变导致 SIFD,9 例中 3 例于幼儿期死亡。
- 患者血清 IL-6、IFN-γ 及 IFN 诱导细胞因子升高,活动性炎症组织活检中可检出 TNF 与 IL-1β。
- 4/4 例接受 TNF 抑制剂治疗后炎症被抑制、输血需求减少、生长改善。
核心结论
- TRNT1 突变导致一种严重且常致命的综合征,将蛋白稳态与自炎症联系起来。
- 生命早期进行分子诊断对于启动抗 TNF 治疗至关重要,抗 TNF 治疗可能预防部分严重疾病后果。
研究设计与样本
- 研究 9 例携带 TRNT1 双等位基因突变并表现为先天性铁粒幼细胞性贫血伴免疫缺陷、发热和发育迟缓(SIFD)的患者。
- 遗传学研究包括全外显子组测序(WES)和候选基因筛查。
- 采用患者原代细胞进行深度 RNA 与 tRNA 测序、细胞因子谱分析、免疫表型分析、免疫印迹和电子显微镜(EM)检查。
主要发现
- 在 9 例患者中鉴定出 8 个突变,其中 3 个此前未与 SIFD 关联。
- 3 例患者于幼儿期死亡。
- 血清中炎症细胞因子(主要为白细胞介素(IL)-6、干扰素 gamma(IFN-γ)及 IFN 诱导细胞因子)升高,而活动性炎症疾病患者组织活检中可检出肿瘤坏死因子(TNF)和 IL-1β。
- 患者成纤维细胞深度 tRNA 测序显示成熟胞质 tRNA 显著缺乏。
- 骨髓和皮肤活检样本 EM 显示所有细胞类型均有显著异常,并见坏死细胞与外观正常细胞混合存在;免疫沉淀发现蛋白清除通路失调的证据。
关键数值与推荐
- 在 9 例患者中鉴定出 8 个 TRNT1 突变,其中 3 个此前未与 SIFD 关联。
- 4/4 例患者接受 TNF 抑制剂治疗后炎症被抑制、输血需求减少、生长改善。
临床怎么用
- 生命早期进行分子诊断对于启动抗 TNF 治疗至关重要,抗 TNF 治疗可能预防部分严重疾病后果。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To characterise the clinical features, immune manifestations and molecular mechanisms in a recently described autoinflammatory disease caused by mutations in TRNT1, a tRNA processing enzyme, and to explore the use of cytokine inhibitors in suppressing the inflammatory phenotype. METHODS: We studied nine patients with biallelic mutations in TRNT1 and the syndrome of congenital sideroblastic anaemia with immunodeficiency, fevers and developmental delay (SIFD). Genetic studies included whole exome sequencing (WES) and candidate gene screening. Patients' primary cells were used for deep RNA and tRNA sequencing, cytokine profiling, immunophenotyping, immunoblotting and electron microscopy (EM). RESULTS: We identified eight mutations in these nine patients, three of which have not been previously associated with SIFD. Three patients died in early childhood. Inflammatory cytokines, mainly interleukin (IL)-6, interferon gamma (IFN-γ) and IFN-induced cytokines were elevated in the serum, whereas tumour necrosis factor (TNF) and IL-1β were present in tissue biopsies of patients with active inflammatory disease. Deep tRNA sequencing of patients' fibroblasts showed significant deficiency of mature cytosolic tRNAs. EM of bone marrow and skin biopsy samples revealed striking abnormalities across all cell types and a mix of necrotic and normal-appearing cells. By immunoprecipitation, we found evidence for dysregulation in protein clearance pathways. In 4/4 patients, treatment with a TNF inhibitor suppressed inflammation, reduced the need for blood transfusions and improved growth. CONCLUSIONS: Mutations of TRNT1 lead to a severe and often fatal syndrome, linking protein homeostasis and autoinflammation. Molecular diagnosis in early life will be crucial for initiating anti-TNF therapy, which might prevent some of the severe disease consequences.
引用
- Giannelou A, Wang H, Zhou Q, et al. Aberrant tRNA processing causes an autoinflammatory syndrome responsive to TNF inhibitors. Ann Rheum Dis. 2018. PMID: 29358286. doi:10.1136/annrheumdis-2017-212401
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。